Related references
Note: Only part of the references are listed.The sphingosine kinase inhibitor SKI-V suppresses cervical cancer cell growth
Yan Zhang et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2022)
The Sphingosine Kinase 2 Inhibitor ABC294640 Restores the Sensitivity of BRAFV600E Mutant Colon Cancer Cells to Vemurafenib by Reducing AKT-Mediated Expression of Nucleophosmin and Translationally-Controlled Tumour Protein
Petra Grbcic et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
An Unanticipated Role for Sphingosine Kinase-2 in Bone and in the Anabolic Effect of Parathyroid Hormone
Joanne M. Walker et al.
ENDOCRINOLOGY (2021)
Evaluation of Amide Bioisosteres Leading to 1,2,3-Triazole Containing Compounds as GPR88 Agonists: Design, Synthesis, and Structure-Activity Relationship Studies
Md Toufiqur Rahman et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Sphingosine kinase-2 is overexpressed in large granular lymphocyte leukaemia and promotes survival through Mcl-1
Francis R. LeBlanc et al.
BRITISH JOURNAL OF HAEMATOLOGY (2020)
Verification of the Necessity of the Tolyl Group of PF-543 for Sphingosine Kinase 1 Inhibitory Activity
Su Bin Kim et al.
MOLECULES (2020)
Amide Bond Bioisosteres: Strategies, Synthesis, and Successes
Shikha Kumari et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Discovery of Harmaline as a Potent Inhibitor of Sphingosine Kinase-1: A Chemopreventive Role in Lung Cancer
Sonam Roy et al.
ACS OMEGA (2020)
In Silico Characterization of Structural Distinctions between Isoforms of Human and Mouse Sphingosine Kinases for Accelerating Drug Discovery
Brittney L. Worrell et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2019)
Topographical Mapping of Isoform-Selectivity Determinants for J-Channel-Binding Inhibitors of Sphingosine Kinases 1 and 2
David R. Adams et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
The sphingosine kinase-1/sphingosine-1-phosphate axis in cancer: Potential target for anticancer therapy
Xiangjin Zheng et al.
PHARMACOLOGY & THERAPEUTICS (2019)
Synthesis and Biological Evaluation of BODIPY-PF-543
Jitendra Shrestha et al.
MOLECULES (2019)
Sphingosine kinase inhibitors: A patent review
Mengda Cao et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2018)
Discovery of a Potent and Selective Sphingosine Kinase 1 Inhibitor through the Molecular Combination of Chemotype-Distinct Screening Hits
Mark E. Schnute et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Mammalian sphingosine kinase (SphK) isoenzymes and isoform expression: challenges for SphK as an oncotarget
Diana Hatoum et al.
ONCOTARGET (2017)
A Phase I Study of ABC294640, a First-in-Class Sphingosine Kinase-2 Inhibitor, in Patients with Advanced Solid Tumors
Carolyn D. Britten et al.
CLINICAL CANCER RESEARCH (2017)
Targeting colorectal cancer cells by a novel sphingosine kinase 1 inhibitor PF-543
TongFa Ju et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
Recent advances in the development of sphingosine kinase inhibitors
Melissa R. Pitman et al.
CELLULAR SIGNALLING (2016)
A novel liposomal formulation of FTY720 (Fingolimod) for promising enhanced targeted delivery
Yicheng Mao et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2014)
Sphingosine Kinase 2 inhibitor SG-12 induces apoptosis via phosphorylation by sphingosine Kinase 2
Miki Hara-Yokoyama et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
Modulation of cellular S1P levels with a novel, potent and specific inhibitor of sphingosine kinase-1
Mark E. Schnute et al.
BIOCHEMICAL JOURNAL (2012)
(R)-FTY720 methyl ether is a specific sphingosine kinase 2 inhibitor: Effect on sphingosine kinase 2 expression in HEK 293 cells and actin rearrangement and survival of MCF-7 breast cancer cells
Keng Gat Lim et al.
CELLULAR SIGNALLING (2011)
Principles of bioactive lipid signalling: lessons from sphingolipids
Yusuf A. Hannun et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
Share Paper
